China Jieya Corporation achieved a revenue of 123 million Yuan in the third quarter of 2024

In the third quarter of 2024, Tongling Jieya Biotechnology Co., Ltd. reported operating revenue of approximately 123 million yuan, a year-on-year decrease of 26.74%. The net profit attributable to shareholders of the listed company was approximately 8.0947 million yuan, down 71.57% year-on-year. The decline in revenue was primarily due to a decrease in product sales prices.